Neoadjuvant treatment of mismatch repair–deficient colon cancer — Clinically meaningful? Editorial
| Author: | Cercek, A. |
| Title: | Neoadjuvant treatment of mismatch repair–deficient colon cancer — Clinically meaningful? |
| Keywords: | controlled study; excision; overall survival; clinical trial; treatment duration; neoadjuvant therapy; cell death; cancer immunotherapy; apoptosis; randomized controlled trial; colonic neoplasms; editorial; pilot study; colon cancer; mismatch repair; colon tumor; dna mismatch repair; long term care; drug therapy; endocrine disease; programmed death 1 receptor; randomized controlled trial (topic); immune checkpoint inhibitor; humans; human; atezolizumab; mismatch repair deficient colon cancer |
| Journal Title: | New England Journal of Medicine |
| Volume: | 390 |
| Issue: | 21 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2024-06-06 |
| Start Page: | 2024 |
| End Page: | 2025 |
| Language: | English |
| DOI: | 10.1056/NEJMe2404601 |
| PUBMED: | 38838316 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Editorial -- Source: Scopus |
